The hospital sector's financial performance in November showed signs of continued stabilization and growth, according to Kaufman Hall’s latest monthly report. Hospitals should "take advantage of the relative stability and re-embrace strategic growth if they hope to see continued success in 2024," stated Erik Swanson, one of the report's authors.
Targeting the growth factors that influence cell proliferation and differentiation in disease is a pretty “well-trodden” field, but Cambridge biotech Scholar Rock purports to take a new spin on the concept. It’s announced a $20 million Series A financing round, and plans to use the funds to move its preclinical work into clinical drug development. Scholar Rock is […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.